X4 Pharmaceuticals, Inc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
X4 Pharmaceuticals, Inc has filed 813 SEC EDGAR filings since 24 Sep 2010

SEC filing history

Showing 101-125 of 146 matching filings.

Per page
25
Current page
5
8-K File 001-38295

8-K

Filing date
30 Jul 2020
Reporting date
29 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38295

8-K

Filing date
11 Jun 2020
Reporting date
10 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38295

8-K

Filing date
07 May 2020
Reporting date
06 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38295

8-K

Filing date
20 Mar 2020
Reporting date
18 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38295

8-K

Filing date
17 Mar 2020
Reporting date
13 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38295

8-K

Filing date
12 Mar 2020
Reporting date
06 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38295

8-K

Filing date
13 Feb 2020
Reporting date
10 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38295

8-K

Filing date
10 Jan 2020
Reporting date
09 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38295

8-K

Filing date
27 Nov 2019
Reporting date
25 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38295

8-K

Filing date
14 Nov 2019
Reporting date
14 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38295

8-K

Filing date
07 Nov 2019
Reporting date
07 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-38295

8-K/A

Filing date
18 Oct 2019
Reporting date
18 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38295

8-K

Filing date
04 Oct 2019
Reporting date
03 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38295

8-K

Filing date
30 Sep 2019
Reporting date
30 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38295

8-K

Filing date
20 Sep 2019
Reporting date
18 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38295

8-K

Filing date
09 Aug 2019
Reporting date
09 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38295

8-K

Filing date
28 Jun 2019
Reporting date
27 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38295

8-K

Filing date
26 Jun 2019
Reporting date
26 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38295

8-K

Filing date
19 Jun 2019
Reporting date
17 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-38295

8-K/A

Filing date
17 May 2019
Reporting date
29 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-38295

8-K/A

Filing date
13 May 2019
Reporting date
11 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38295

8-K

Filing date
15 Apr 2019
Reporting date
12 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .